Effects of exogenous estradiol-17 beta on luteinizing hormone, progesterone, and estradiol-17 beta concentrations before and after prostaglandin F2 alpha-induced termination of pregnancy and pseudopregnancy in gilts.

This study evaluated the influence of exogenous estradiol-17 beta (E2) administration on LH concentrations and the number of animals returning to estrus after the termination of pregnancy or pseudopregnancy in gilts. Gilts were mated (pregnant; n = 11) on the 1st d of estrus or received 5 mg of estradiol valerate i.m. at d 11 to 15 after the onset of estrus (pseudopregnant; n = 9). Gilts were treated with prostaglandin F2 alpha (PGF2 alpha, 15 and 10 mg) at 12-h intervals on d 44 of pregnancy or pseudopregnancy. The day of abortion or luteolysis (progesterone less than .2 ng/mL) was considered d 0. Six pregnant and four pseudopregnant gilts received s.c. an E2 capsule (24 mg of E2) on d -20 and additional E2 capsules on d -13 and -6. The E2 capsules were removed on the day after PGF2 alpha administration. Blood samples were collected at 12-h intervals from d -21 to -3, at 6-h intervals from d -2 to 21 or the onset of estrus, and at 15-min intervals for 8 h on d -2, 1, 4, 7, 10, 14, and 18. After each 8-h sampling period, gilts were treated i.v. with GnRH at .5 micrograms/kg of BW and blood samples collected at 10-min intervals for 3 h. A greater (P less than .05) proportion of sham-treated gilts than of E2-treated gilts exhibited a preovulatory-like LH surge after abortion/luteolysis. It was evident that E2 supplementation before luteolysis reduced the ability of pregnant and pseudopregnant gilts to return to estrus.     

Dose-response shift in the ability of gilts to remain pregnant following exogenous estradiol-17 beta exposure

Sixty mated gilts were assigned to a 2 X 6 factorial arrangement (n = 5) of day of injection (d 9 and 10 vs 12 and 13; d 0 = first day of estrus) and dose of estradiol-17 beta (0, .125, .5, 2, 8 and 32 mg X gilt-1 X d-1). Gilts were subsequently slaughtered on d 30; pregnancy was verified and percent embryonic survival calculated. A 64-fold shift in the dose-response curve for percent embryonic survival illustrated that the adverse effects of exogenous estradiol-17 beta were less when administered on d 12 and 13 as compared with d 9 and 10 (day X dose, P less than .01). This experiment demonstrated that the uterine-embryonic environment of d 12 and 13 pregnant gilts was more tolerant of exogenous estrogen alterations than that of d 9 and 10 pregnant gilts.     

Concentration of IGF-I and estradiol-17beta in the blood plasma of pregnant cattle

Blood samples were collected from pregnant cows, heifers and also from non pregnant cows serving as controls. The determination of insulin-like-growth-factor-I (IGF-I) and estradiol-17 beta (E2) were performed immunologically. In the non pregnant cows E2 remained unchanged. IGF-I decreased around parturition and increased again commencing the 6th week of lactation. Compared to nonpregnant animals E2 but not IGF-I was slightly elevated during the first 10 weeks of pregnancy. During the 10th up to 20th week of pregnancy the mean values of IGF-I were increased as well as the ones of E2. During the late pregnancy the values of IGF-I in heifers are obviously more elevated as in lactating pregnant or non-pregnant cows; analogous high values were determined in pregnant cows only during the dry period. Before parturition even a negative correlation exists between IGF-I and E2. It is concluded that IGF-I is predominantly regulated by other factors.     

The concentration of estradiol-17 beta in bovine semen

This study was conducted to evaluate the influence of age, breed, epididymectomy and semen processing on the concentration of estradiol-17 beta (E2) in bovine semen. Semen was collected either by electroejaculation or with an artificial vagina. Neat semen samples were stored at -20 C until analysis. Processed, frozen semen and an egg yolk-citrate semen extender were obtained from a commercial semen processing firm and stored in liquid nitrogen at -196 C. The concentration of E2 in semen was determined by radioimmunoassay. Semen from mature (greater than 24 mo), fertile Brahman (n = 19), Brangus (n = 16), Charolais (n = 29), Holstein (n = 15) and Santa Gertrudis (n = 25) bulls was analyzed for E2 concentration, and no difference (P greater than .10) between breeds was found. There was no difference (P greater than .10) in seminal E2 concentration between mature, fertile bulls (n = 104) and epididymectomized bulls (n = 22). In semen collected from prepuberal (12 to 16 mo, n = 21), peripuberal (17 to 20 mo, n = 17) and mature (greater than 24 mo, n = 19), Brahman bulls, the mature bulls had a lower (P less than .01) semen E2 concentration than peripuberal and prepuberal bulls. There were no differences (P greater than .10) in seminal E2 concentration among peripuberal Angus (n = 8), Hereford (n = 8) and Brahman (n = 17) bulls.(ABSTRACT TRUNCATED AT 250 WORDS)     

Effects of season and estradiol-17 beta on luteinizing hormone release in ovariectomized sows.

This study examined the ability of estradiol-17 beta (E2) to suppress LH release in the sow during different months of the year. Six chronically ovariectomized sows were fitted with vena caval cannulas (d 0) and blood samples were collected at 6-h intervals for 6 d. Sows were treated s.c. with E2 capsules (24 mg of E2/275 kg of BW) at d 3. Additional blood samples were collected at 15-min intervals for 8 h on d 2 and 5. After each 8-h frequent sampling period, sows were treated i.v. with GnRH at .5 microgram/kg of BW, and blood samples were collected at 10-min intervals for 3 h. The protocol was repeated at monthly intervals for 13 mo. Luteinizing hormone concentrations were determined for all serum samples, and E2 concentrations were quantified in samples collected at 6-h intervals. Data were analyzed by split-block analyses of variance. Serum E2 concentrations increased (P less than .001) from 5.0 +/- .3 pg/ml before E2 treatment to 26.0 +/- .2 pg/ml after E2 treatment. The interval from GnRH administration to peak LH concentration was shorter (P less than .001) before E2 treatment than after E2 treatment (28.7 +/- 2.2 vs 71.0 +/- 2.2 min). It was evident that baseline LH, mean LH, pulse frequency, and pulse amplitude and LH release after GnRH administration failed to demonstrate seasonal changes. In summary, LH release was suppressed after treatment with E2 and was affected minimally by month of the year. In addition, E2 inhibitory effects of LH release included hypothalamic and anterior pituitary sites of action.     

Uterine involution in mares treated with progesterone and estradiol-17 beta

Bacteriology, histology, and scanning electron microscopy were used to evaluate uterine involution in 27 mares treated with daily injections of 150 mg of progesterone and 10 mg of estradiol-17 beta, commencing within 18 hours of parturition. These findings were compared with those for 24 untreated mares at postpartum day 10 or 11. The treatment resulted in significantly (P less than 0.05) greater uterine gland proliferation. Gland density was significantly (P less than 0.05) greater in mares treated for 6 to 10 days than in those treated 2 to 5 days. The proportion of ciliated cells to secretory cells lining the endometrial surface was significantly (P less than 0.05) greater in mares during delayed foal estrus than in those at postpartum days 10 to 11. The proportion of ciliated to secretory cells increased with increasing duration of treatment. It was concluded that treatment with progesterone and estradiol-17 beta allowed additional time for uterine involution in the early postpartum period.     

Relationship between endogenous estradiol-17 beta and estrous behavior in heifers

Thirty-five Holstein heifers were used to examine the relationship between endogenous estradiol-17 beta and estrous traits. During a non-superovulation period (NSP), estrous cycles were synchronized and during the periovulatory stage blood samples were collected every 6 h for 120 h for subsequent determination of estradiol-17 beta and progesterone. In addition, continuous observation for estrous behavior was performed for 98 h. A gonadotropin-induced superovulation period (SP) was begun 12 d after estrus was detected during NSP. Heifers were injected with FSH twice daily for 4 d and single injections of prostaglandin were given on d 14 and 15. Beginning at d 14, blood samples were collected every 6 h for 120 h for subsequent determination of estradiol-17 beta and progesterone. Continuous observation for estrous behavior was performed for 98 h. Peak estradiol-17 beta was greater during SP than during NSP (49.0 +/- 3.1 vs 12.9 +/- 3.0 pg/ml serum). Thirty-three and 31 of the 35 heifers were in estrus during NSP and SP, respectively; duration of estrus was 2.3 h longer during SP than during NSP. However, number of behavioral interactions during estrus did not differ between NSP and SP. In conclusion, estrous traits were similar, whereas peak estradiol-17 beta concentrations were markedly different between NSP and SP.     

Follicular fluid concentrations of estradiol-17 beta and progesterone and secretory patterns of LH and FSH in prepubertal gilts reared in confinement or outdoor lots

One-hundred-twenty crossbred gilts from two experiments were assigned randomly to a 2 X 5 factorial experiment. Gilts were reared in two environments (confinement or outside) and assigned to be slaughtered at 4, 5, 6, 7 or 8 mo of age. Beginning at 6 mo of age, blood samples were taken at weekly intervals from each gilt via venipuncture. Serum concentrations of progesterone were analyzed to determine when gilts attained puberty. On the day prior to slaughter, six pigs within a treatment group were cannulated and blood samples were taken at 20-min intervals for 4 h. At slaughter, follicular fluid (FF) was aspirated and the volume determined from those follicles having a diameter of at least 4 mm. No effect of environment was found on the proportion of gilts that attained puberty by 8 mo of age. For the 12 gilts that reached puberty during the study, the age at puberty for gilts reared in outdoor lots (202 +/- 5 d) was less (P less than .05) than those reared in confinement (224 +/- 8 d). Mean concentrations of serum luteinizing hormone (LH; P = 98) and number of secretory spikes of LH (P = .76) were similar between gilts reared in confinement and those reared in outdoor lots. No differences in average serum concentrations of follicle stimulating hormone (FSH) or number of secretory spikes of FSH were found between gilts subjected to these environments (P = .95). Concentrations of estradiol-17 beta in FF were not affected by environment or age (P greater than .25).(ABSTRACT TRUNCATED AT 250 WORDS)     

In vitro glucuronidation of estradiol-17beta by microsomes prepared using liver biopsy specimens from dairy cows

Increased hepatic metabolism of estradiol may cause weakened estrous behavior in lactating dairy cows, but this hypothesis must be examined further, especially through diachronic study of the hepatic estradiol-17beta glucuronidation activity of uridine diphosphate (UDP)-glucuronosyltransferases. Therefore, in order to develop a new tool for this purpose, we attempted to conduct biopsy of the livers of dairy cows with the aid of ultrasonography and to measure the UDP-glucuronosyltransferase activities of microsomes of the specimens using in vitro glucuronidation followed by HPLC analysis. We were able to measure the activities of the microsomes prepared from the liver biopsy, and the results seemed reliable. Therefore, this method may become a new tool in clinical studies to detect estradiol-17beta glucuronidation activity.     

Effect of estradiol-17beta administration during the time of conceptus elongation on placental size at term in Meishan pigs

Meishan embryos transferred to recipient females on d 2.5 are larger, contain greater numbers of trophectoderm cells, and secrete greater amounts of estradiol-17beta (E2beta) when gestated in a Yorkshire as compared with Meishan uterus to d 12. Additionally, placentas of Meishan conceptuses are larger when gestated in a Yorkshire as compared with Meishan uterus throughout gestation. Embryonic E2beta secretion during elongation on d 12 to 13 of gestation is temporally associated with endometrial secretion of growth factors, including IGF-I, which has been shown to increase mitotic rate in the trophectoderm of pig embryos. This experiment was conducted to determine whether E2beta administration to Meishan gilts at the time of conceptus elongation would increase placental size at term. Meishan gilts (n = 12) were checked twice daily for estrus (0700 and 1900), and each was bred to a Meishan boar at 0 and 24 h after the onset of estrus (d 0). Gilts were randomly assigned in equal numbers to receive injections of sesame oil (VEH) starting on d 12 (control), 1 mg of E2beta in VEH starting on d 12 (E212), or 1 mg of E2beta in VEH starting d 13 (E(2)13). The injections were initiated at 0700 or 1900 (corresponding to the time of day they first exhibited estrus) and continued at 6-h intervals for 48 h, resulting in 8 mg of E2beta given in eight injections. Pregnant gilts were killed on d 112 of gestation, and ovulation rate, litter size, implantation site length, fetal weight, crown-rump length, placental weight, and placental surface area were quantified. There were no differences among E(2)12, E(2)13, and control females in ovulation rate or litter size, which averaged 16.3 +/- .7 and 11.8 +/- .7, respectively. Fetal weight and crown-rump length were not different (P > .10) among E(2)12, E(2)13, and control females, averaging 802 +/- 26 g and 24.3 +/- .3 cm. Placentas were markedly heavier (176 +/- 14 and 174 +/- 16 vs 134 +/- 10 g, P < .05) and larger (1,337 +/- 97 and 1,520 +/- 70 vs 978 +/- 29 cm2, P < .001) for E(2)12 and E(2)13 vs control gilts, respectively. Placental efficiency (estimated as fetal weight:placental weight) was greater (P < .05) in the control than in the E(2)12 and E(2)13 gilts (5.8 +/- .2 vs 4.8 +/- .2 and 5.1 +/- .4). These data demonstrate that the amount of E2beta exposure around the time of elongation affects placental size at term. Additionally, the difference in placental efficiency between control and E2beta groups indicate that E2beta-induced increases in placental size led to a reduced placental efficiency.     

Relationship between testicular transferrin and plasma estradiol-17beta concentrations of dogs with azoospermia and dogs with sertoli cell tumors.

Testicular Transferrin (Tf) and peripheral plasma estradiol-17beta (E2) concentrations were measured in 3 dogs with azoospermia (AZ dogs), 3 dogs with Sertoli cell tumors (SC dogs), and 5 normal male Beagles. The mean Tf concentrations in the testes of the AZ dogs and the affected testes of the SC dogs, and the plasma E2 concentrations in both these groups of dogs were significantly higher than the values in normal dogs (P<0.05, 0.01 and 0.01, respectively). Therefore, excessive E2 secretion by hyperfunctioning Sertoli cells is thought to have caused the azoospermia in the 3 dogs.     

Factors affecting retention of estradiol-17 beta silicone rubber implants in ears of steers

A series of trials were conducted to identify the factors causing loss of estradiol-17 beta (E2-beta) silicone rubber implants from the ears of cattle and to evaluate methods of reducing this loss. Surface application of cattle feces to the ears before implanting resulted in an increase in loss of implants compared with the loss from dry, clean ears (30.6 vs 8.6%; P less than .05). Washing ears with a povidone-iodine antiseptic solution before implanting or treating implant sites with an antibiotic after implanting reduced (P less than .05) implant loss when ears were coated with the fecal slurry. Coating silicone rubber implants with .5 to 2 mg of oxytetracycline hydrochloride (OTC) reduced (P less than .0001) implant loss from 39.8 to 13.8% when ears were coated with fecal slurry. When silicone rubber implants with a 1.5-mg coating of OTC were implanted in cattle before submerging in a dipping vat, implant loss was reduced from 6.2 to 2.7%. In studies designed to evaluate mechanical factors affecting implant loss, implants that were placed in the middle of the ear in tight skin moved .79 cm toward the insertion site during a 14-d period after administration compared with 2.82 cm when placed in the base of the ear. When placed in the middle of the ear in tight skin, only 2 of 399 (.5%) implants were lost from steers submerged in a dipping vat immediately following implantation compared with 42 of 394 (10.7%) when placed in the base of the ear (P less than .0001).(ABSTRACT TRUNCATED AT 250 WORDS)     

Skeletal muscle protein metabolism and serum growth hormone, insulin, and cortisol concentrations in growing steers implanted with estradiol-17 beta, trenbolone acetate, or estradiol-17 beta plus trenbolone acetate.

Skeletal muscle protein degradation, measured by urinary N tau-methylhistidine excretion, and circulating concentrations of growth hormone (GH), insulin (INS), and cortisol (CT) were monitored in steers before and after implantation with estradiol-17 beta (E2; 24 mg) and trenbolone acetate (TBA; 300 mg). Yearling crossbred steers (n = 43) were randomly assigned to four treatment groups in a 2 x 2 factorial arrangement: nonimplanted controls (C); TBA; E2; and TBA plus E2 (TBA+E2). A subgroup (Block 1) of 16 steers was bled on d -12, 31, and 72 after implanting. Deposition of skeletal muscle protein was markedly increased (P less than .001) by E2 and TBA+E2 treatment. This response occurred mainly within the first 40 d after implantation and declined (P less than .001) in concert with decreasing (P less than .01) concentration of serum E2. Anabolic steroid treatment did not affect the rate of skeletal muscle protein breakdown. There was no apparent relationship between reduced serum CT concentration (linear effect; P less than .01) in TBA-treated steers and skeletal muscle protein degradation rate. Blood concentration and pulse activity of INS were not affected by anabolic steroid administration. Both TBA- and TBA+E2-implanted steers displayed a linear decrease (P less than .05) in serum GH concentration over time, which was similar to C. Lowered mean GH concentration resulted from a reduction (TBA main effect; P less than .05) in pulse amplitude of GH. Unlike TBA, TBA+E2, and C, only E2 maintained serum GH concentrations over time. Although increased muscle protein deposition was evident in TBA+E2-treated steers, an obvious causal relationship between this response and circulating GH, INS, and CT was not revealed. These results do not support the concept that combined androgenic agent and estrogen administration effectively reduce bovine muscle protein degradation by static modulation of circulating endogenous anabolic and antianabolic hormones.